Showing results (1221-1230 of 1,435) with videos related to

Sort By:
Pageof 144
Microbial Genomics|April 21, 2022
Characterisation of the symbionts in the Mediterranean fruit fly gutMike Darrington, Philip T Leftwich, Neil A Holmes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 27, 2018
From neuroscience to evidence based psychological treatments - The promise and the challenge, ECNP March 2016, Nice, FranceGuy M Goodwin, Emily A Holmes, Erik Andersson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1987
Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusionR D Neirinckx, L R Canning, I M Piper, et al.
The Journal of Clinical Endocrinology and Metabolism|May 16, 2018
Postnatal Lifestyle Intervention for Overweight Women With Previous Gestational Diabetes: A Randomized Controlled TrialValerie A Holmes, Claire R Draffin, Chris C Patterson, et al.
Psychiatry Research|October 23, 2012
Optimism and mental imagery: a possible cognitive marker to promote well-being?Simon E Blackwell, Nathaly Rius-Ottenheim, Yvonne W M Schulte-van Maaren, et al.
Journal of Behavior Therapy and Experimental Psychiatry|May 1, 2019
Visuospatial computer game play after memory reminder delivered three days after a traumatic film reduces the number of intrusive memories of the experimental traumaHenrik Kessler, Anna-Christine Schmidt, Ella L James, et al.
Neurobiology of Pain (Cambridge, Mass.)|January 1, 2020
Biological and behavioral markers of pain following nerve injury in humansS A Holmes, N Barakat, M Bhasin, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal InfectionsJon P Furuno, Gregory B Tallman, Brie N Noble, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I resultsF A Holmes, V Valero, R S Walters, et al.
Pageof 144